Geneos Wealth Management Inc. Uni Qure N.V. Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$13.15 - $20.45 $1,262 - $1,963	-96 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $1,395 - $2,064	96 New	96 $1,000
Q2 2021 Jul 08, 2021	SELL	$29.97 - $37.17 $272,337 - $337,763	-9,087 Closed	0 $0
Q1 2021 Jun 17, 2021	BUY	$29.24 - $42.03 $265,703 - $381,926	9,087 New	9,087 $293,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.